Emcure Pharmaceuticals IPO — Listing Performance
Emcure Pharmaceuticals IPO facts & figures
| Issue category | Mainboard |
|---|---|
| Issue open date | 3 Jul 2024 |
| Listing date | 10 Jul 2024 |
| Issue price | ₹1,008 |
| Listing-day close | ₹1,359.15 (34.84%) |
| Recent market price | ₹1,978.90 (96.32% vs issue) |
| 52-week range | ₹1,271.80 – ₹2,009.60 |
| Identifiers | NSE: EMCURE · ISIN: INE168P01015 |
How the listing went
Emcure Pharmaceuticals had a strong market debut, ending listing day 34.84% over the issue price.
Emcure Pharmaceuticals against every other debut on record
- Rank in 2024: 124 of 262 NSE debuts, on a 34.84% first-day close.
- 66th percentile of 86 mainboard debuts in 2024 (median 21.06%).
- 17th of 27 debuts in July 2024.
- Opened 31.45% above issue, then added 3.39 points to the close.
- Day-one range ₹1,325.05 to ₹1,385: a 5.95% swing on the issue price.
- Last close ₹1,978.90 (11 Sep 2026): 96.32% above issue, against 34.84% on day one.
- 96% up its 52-week range of ₹1,271.80 to ₹2,009.60.
- Priced at the top of the ₹960 to ₹1,008 band.
- Listed 5 calendar days after close.
- All 508 mainboard debuts on record: median 12.01%, 72% closed above issue.
Computed over 1109 verified NSE debuts to 11 Sep 2026 · sources